Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Fish and Richardson
Cantor Fitzgerald

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: RE37035

« Back to Dashboard

Summary for Patent: RE37035

Title: Phenylacetic acid benzylamides
Abstract:Phenylacetic acid benzylamides having the following general structure ##STR1## wherein the substituents are defined herein, are disclosed, which compounds are hypoglcemic agents.
Inventor(s): Grell; Wolfgang (Biberach, DE), Hurnaus; Rudolf (Biberach, DE), Griss; Gerhart (late of Biberach, DE), Sauter; Robert (Laupheim, DE), Reiffen; Manfred (Biberach, DE), Rupprecht; Eckhard (Guntramsdorf, AT)
Assignee: Boehringer Ingelheim KG (Ingelheim, DE)
Application Number:08/946,602
Patent Claim Types:
see list of patent claims
Compound; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: RE37035

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3347565Dec 30, 1983
Germany3522604Jun 25, 1985
Germany3523466Jul 01, 1985

International Patent Family for Patent: RE37035

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain8802145► Subscribe
Denmark613184► Subscribe
Denmark167439► Subscribe
Denmark296686► Subscribe
Denmark167573► Subscribe
Denmark310986► Subscribe
Denmark168741► Subscribe
European Patent Office0147850► SubscribeSPC/GB98/042United Kingdom► Subscribe
European Patent Office0147850► Subscribe99C0002Belgium► Subscribe
European Patent Office0207331► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Express Scripts
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus